Table 3 Side effects severity among sex and history of COVID-19.

From: Antibody response and seroprevalence in healthcare workers after the BNT162b2 vaccination in a University Hospital at Tokyo

 

Minor side effects (N = 2047)

Major side effects (N = 112)

p value

Sex, n (%)

Males

711(97.5%)

18 (2.5%)

< 0.0001

Females

1336 (93.4%)

94 (6.6%)

COVID-19 history, n (%)

Yes

17 (100%)

0 (0.0%)

> 0.9999

No

2030 (94.8%)

112 (5.2%)

Back to article page